Nomura Holdings Inc Uni Qure N.V. Transaction History

Nomura Holdings Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$5.63 - $8.27 $531,111 - $780,158	94,336 Added 943.36%	104,336 $706,000
Q3 2023 Nov 14, 2023	BUY	$6.71 - $11.83 $67,100 - $118,300	10,000 New	10,000 $67,000
Q1 2023 May 15, 2023	BUY	$18.7 - $23.07 $241,155 - $297,510	12,896 New	12,896 $259,000
Q3 2022 Nov 15, 2022	BUY	$16.98 - $25.54 $1.75 Million - $2.63 Million	103,137 New	103,137 $1.94 Million

142

35.3M

1.54M

389K

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $300M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

Stay updated on Nomura Holdings Inc with notifications on news.